Fabio
109 lines
7.1 KiB
Markdown
109 lines
7.1 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Xylazine; penalty for manufacturing, selling, etc., for human consumption."
|
||
description: "Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to HB 1187."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2024"
|
||
identifier: "SB 614"
|
||
citation: "Virginia SB 614 (2024)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Todd E. Pillion"]
|
||
version_count: 4
|
||
action_count: 40
|
||
vote_count: 9
|
||
first_action: "2024-01-10"
|
||
last_action: "2024-04-04"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/15bd4fe9-3513-4765-8c0d-68a8d86fbd48"
|
||
source_url: "https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB614"
|
||
source_hash: "c218d0b361e1d64ecb81ce736b6f467409389ed75a14d0f6e0cc236d8a8b9758"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia SB 614 (2024) — Xylazine; penalty for manufacturing, selling, etc., for human consumption.
|
||
|
||
Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to HB 1187.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **CHAP0516** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?241+ful+CHAP0516)
|
||
2. **Committee substitute printed 24106043D-S1** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?241+ful+SB614S1)
|
||
3. **Prefiled and ordered printed; offered 01/10/24 24104627D** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?241+ful+SB614)
|
||
4. **SB614ER** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?241+ful+SB614ER)
|
||
|
||
## Votes
|
||
|
||
- VOTE: Block Vote Passage (96-Y 0-N) — **95–0** (pass) · lower
|
||
- Reported from Courts of Justice (15-Y 0-N) — **15–0** (pass) · upper
|
||
- Reported from Education and Health with substitute (15-Y 0-N) — **15–0** (pass) · upper
|
||
- Reported from Finance and Appropriations (15-Y 0-N) — **15–0** (pass) · upper
|
||
- Constitutional reading dispensed (40-Y 0-N) — **40–0** (pass) · upper
|
||
- Reported from Appropriations (22-Y 0-N) — **22–0** (pass) · lower
|
||
- Constitutional reading dispensed (40-Y 0-N) — **40–0** (pass) · upper
|
||
- Passed Senate (40-Y 0-N) — **40–0** (pass) · upper
|
||
- Reported from Courts of Justice (22-Y 0-N) — **22–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Todd E. Pillion — primary (person)
|
||
- Tara A. Durant — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2024-01-10** Prefiled and ordered printed; offered 01/10/24 24104627D `filing, introduction`
|
||
- **2024-01-10** Referred to Committee on Education and Health `referral-committee`
|
||
- **2024-01-12** Impact statement from VCSC (SB614)
|
||
- **2024-01-16** Assigned Education and Health Sub: Health Professions `referral-committee`
|
||
- **2024-01-25** Impact statement from DPB (SB614)
|
||
- **2024-01-26** Senate subcommittee amendments and substitutes offered
|
||
- **2024-02-01** Reported from Education and Health with substitute (15-Y 0-N) `committee-passage`
|
||
- **2024-02-01** Committee substitute printed 24106043D-S1 `substitution`
|
||
- **2024-02-01** Rereferred to Courts of Justice `referral-committee`
|
||
- **2024-02-02** Impact statement from VCSC (SB614S1)
|
||
- **2024-02-05** Reported from Courts of Justice (15-Y 0-N) `committee-passage`
|
||
- **2024-02-05** Rereferred to Finance and Appropriations `referral-committee`
|
||
- **2024-02-05** Impact statement from DPB (SB614S1)
|
||
- **2024-02-07** Reported from Finance and Appropriations (15-Y 0-N) `committee-passage`
|
||
- **2024-02-08** Constitutional reading dispensed (40-Y 0-N)
|
||
- **2024-02-09** Read second time `reading-2`
|
||
- **2024-02-09** Reading of substitute waived
|
||
- **2024-02-09** Committee substitute agreed to 24106043D-S1 `substitution`
|
||
- **2024-02-09** Engrossed by Senate - committee substitute SB614S1 `substitution`
|
||
- **2024-02-09** Constitutional reading dispensed (40-Y 0-N)
|
||
- **2024-02-09** Passed Senate (40-Y 0-N) `passage`
|
||
- **2024-02-15** Placed on Calendar
|
||
- **2024-02-15** Read first time `reading-1`
|
||
- **2024-02-15** Referred to Committee for Courts of Justice `referral-committee`
|
||
- **2024-02-16** Reported from Courts of Justice (22-Y 0-N) `committee-passage`
|
||
- **2024-02-16** Referred to Committee on Appropriations `referral-committee`
|
||
- **2024-02-21** Reported from Appropriations (22-Y 0-N) `committee-passage`
|
||
- **2024-02-23** Read second time `reading-2`
|
||
- **2024-02-26** Read third time `reading-3`
|
||
- **2024-02-26** Passed House BLOCK VOTE (96-Y 0-N) `passage`
|
||
- **2024-02-26** VOTE: Block Vote Passage (96-Y 0-N) `passage`
|
||
- **2024-02-29** Enrolled `enrolled`
|
||
- **2024-02-29** Bill text as passed Senate and House (SB614ER) `passage`
|
||
- **2024-02-29** Impact statement from DPB (SB614ER)
|
||
- **2024-02-29** Signed by Speaker `passage`
|
||
- **2024-03-03** Signed by President `passage`
|
||
- **2024-03-11** Enrolled Bill Communicated to Governor on March 11, 2024 `enrolled`
|
||
- **2024-03-11** Governor's Action Deadline 11:59 p.m., April 8, 2024 `executive-receipt`
|
||
- **2024-04-04** Approved by Governor-Chapter 516 (effective 7/1/24) `executive-signature`
|
||
- **2024-04-04** Acts of Assembly Chapter text (CHAP0516)
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/15bd4fe9-3513-4765-8c0d-68a8d86fbd48`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|